即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 2376257-44-0 | 货号 | BCP49211 |
中文名 | Bexotegrast | ||
英文名 | Bexotegrast | ||
中文别名 | |||
英文别名 | PLN-74809;PLN 74809;PLN74809; | ||
SMILES | COCCN(CCCCC1=NC2=C(CCCN2)C=C1)CCC(C(=O)O)NC3=NC=NC4=CC=CC=C43 | ||
化学名称 | |||
分子式 | C27H36N6O3 | 分子量 | 492.61 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Bexotegrast is a small-molecule that dually inhibits both αvβ6 and αvβ1 to treat both idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC). The compound was granted orphan drug designation by the US FDA in August 2018 for treatment of IPF, and Pliant Therapeutics recently raised $100 million in Series C financing to support further clinical development of this compound. Phase 2a studies are currently evaluating PLN-74809 safety and efficacy for participants with IPF (NCT04396756)across 10 participating countries, and for participants with PSC (NCT04480840). In addition, the compound is also currently in Phase 2a trials (NCT04565249) for the treatment of COVID-19 related acute respiratory distress syndrome. |
相关产品推荐
查看更多 >Tags:Bexotegrast 供应商,Bexotegrast 购买,Bexotegrast 生产,Bexotegrast 批量,Bexotegrast 供应,Bexotegrast 订购,Bexotegrast 采购